Skip to main content
Clinical Trials/CTRI/2017/12/011033
CTRI/2017/12/011033
Other
Phase 3

ong term growth and developmental outcomes following post discharge multistrain probiotic supplementation in preterm neonates less than 33 weeks of gestation- An RCT

Surya Childrens Medicare Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Surya Childrens Medicare Pvt Ltd
Status
Other
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Surya Childrens Medicare Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • All preterm NICU graduates born less than 33 weeks of gestation will be randomised to the two study groups at 3 weeks post discharge
  • The 3 week cutoff is because these infants routinely receive probiotics during NICU stay. A wash out period of 3 weeks might be need to rule out continued effects of initial probiotic supplementation in the placebo group.

Exclusion Criteria

  • Parental refusal for consent and families living out of Mumbai

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not Yet Recruiting
N/A
Developmental outcomes and associated factors in pediatric patients with global delay development following rehabilitation: A retrospective case-control studyPediatric patients with global delay development following rehabilitationGlobal delay development , Delay development, Denver II, pediatric rehabilitation, denver developmental screening test II, developmental quotient
TCTR20210705002/A54
Active, Not Recruiting
Phase 1
Short-term and longterm growth in children with asthma treated with budesonide or montelukast
EUCTR2006-003013-41-DKChildren's Clinic Randers60
Active, Not Recruiting
Phase 1
Growth and Development Study of Alglucosidase Alfa.Pompe diseaseMedDRA version: 20.1Level: PTClassification code 10053185Term: Glycogen storage disease type IISystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2021-005552-11-Outside-EU/EEAGenzyme Corporation
Completed
N/A
A prospective, longitudinal study of growth, nutrition and sedentary behaviour in young children with cerebral palsy to measure growth, dietary intake, physical activity, participation, health resource use and quality of lifeCerebral PalsyMusculoskeletal - Other muscular and skeletal disordersNeurological - Other neurological disorders
ACTRN12611000616976niversity of Queensland182
Not Yet Recruiting
N/A
The effects of a newly designed stepwise functional appliance on growth and development in Class II mandibular deficient patients.Class II mandibular deficiency.Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disorders
ACTRN12610000298011The University of Sydney, Faculty of Dentistry30